Physical Exercise as Treatment Post-stroke Fatigue - a Feasibilty Study.

NCT07206147 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-10-03

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the feasibility the treatment FaStEx (FatigueStrokeExercise) which consists of strength exercise in people with brain fatigue after stroke, referred to as post-stroke fatigue. The main questions it aims to answer are:

* What is the feasibility of a study with the treatment FaStEx, structured physical training, for people with post-stroke fatigue?
* What factors are important for people with post-stroke fatigue to be able to complete the FaStEx treatment?
* How do people with post-stroke fatigue experience participation in the study with the FaStEx treatment?

Researchers will compare FaStEx to physical activity at home to see if FaStEx can reduce post-stroke fatigue.

Participants will

* Carry out strength training twice a week at a health care center.
* Carry out physical activity for at least 150 minutes per week on their own. Participants in the control group will carry out this physical activity as well.
* The treatment lasts for eight weeks.

Conditions

Interventions

OTHER

FaStEx - Structured strength training

Strength training in group session, 2 times a week for 8 weeks. 150 minutes of physical activity per week that is carried out independently.

OTHER

Control group

150 minutes of physical activity per week that is carried out independently.

Sponsors & Collaborators

  • Örebro University, Sweden

    collaborator OTHER
  • Strokeförbundet

    collaborator UNKNOWN
  • Hjärnskadefonden

    collaborator UNKNOWN
  • Region Örebro County

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-06-01
Completion
2026-06-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07206147 on ClinicalTrials.gov